Beta-cell damage in diabetic insulitis: are we approaching a solution?
D000917:Antibody Formation; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D004702:Endocrine Glands / Q000276:immunology; D005786:Gene Expression Regulation; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000032:analysis; D007165:Immunosuppression Therapy; D007328:Insulin / Q000276:immunology*; D007515:Islets of Langerhans / Q000276:immunology*
D001323:Autoantibodies; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007074:Immunoglobulin G; D007328:Insulin